Literature DB >> 28065557

Manual laryngeal fixation facilitates tracheal intubation during chest compression: A randomized crossover manikin study.

Takanobu Fujisawa1, Nobuyasu Komasawa2, Kazuo Hattori1, Ryosuke Mihara1, Toshiaki Minami1.   

Abstract

PURPOSE: We compared the effectiveness of external manual laryngeal fixation (MLF) for tracheal intubation during chest compression using three laryngoscopes, the Macintosh laryngoscope (McL), McGRATH® MAC (McGRGTH), and Pentax-AWS Airwayscope® (AWS) on an adult manikin.
METHODS: Sixteen novice doctors and 15 experienced anesthesiologists performed tracheal intubation during chest compression on an adult manikin using the McL, McGRATH, and AWS with or without MLF. Tracheal intubation time and intubation success rate were measured.
RESULTS: In the AWS trial, all novice and experienced doctors successfully secured the airway with or without MLF during chest compression. In McL and McGRATH trials, MLF significantly improved the rate of successful intubation during chest compression compared to without MLF for novice doctors. While intubation time did not significantly differ with or without MLF in the AWS trial, MLF significantly shortened intubation time in McL and McGRATH trials for both novice and experienced doctors.
CONCLUSION: These findings suggest that MLF facilitates tracheal intubation with the McL and McGRATH during chest compression.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Chest compression; Manual laryngeal fixation; Simulation; Tracheal intubation

Mesh:

Year:  2016        PMID: 28065557     DOI: 10.1016/j.ajem.2016.12.063

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  1 in total

1.  Comparison of i-Gel as a Conduit for Intubation between under Fiberoptic Guidance and Blind Endotracheal Intubation during Cardiopulmonary Resuscitation: A Randomized Simulation Study.

Authors:  Hyun Young Choi; Wonhee Kim; Yong Soo Jang; Gu Hyun Kang; Jae Guk Kim; Hyeongtae Kim
Journal:  Emerg Med Int       Date:  2019-10-31       Impact factor: 1.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.